“Benefits of Advanced Pneumatic Compression Devices in Patients with Phlebolymphedema”

BHIPeer Reviewed Articles

Journal of Vascular Surgery, June 2018

This was a longitudinal matched case-control analysis of deidentified private insurance claims. The study used administrative claims data from Blue Health Intelligence® for the complete years 2012 through 2016. Patients were continuously enrolled for at least 18 months, diagnosed with phlebolymphedema, and received at least one claim for CONS either alone or in addition to pneumatic compression (SPCDs or APCDs).